At least five people have been diagnosed with Legionnaires’ disease in Central Harlem, the NYC Department of Health said ...

Affinity Technologies’ CyPath Lung, noninvasive lung cancer diagnostic receives Canadian patent: San Antonio, Texas Thursday, July 24, 2025, 11:00 Hrs [IST] bioAffinity Techn ...

BARREN COUNTY, KY.- Last July, TJ Regional Health introduced a groundbreaking form of medical technology that is changing the ...

Canada grants bioAffinity Technologies new patent that protects its proprietary technology that powers its flagship product, ...

Know how lung cancer is increasingly affecting non-smokers due to factors like air pollution, genetics, and second-hand smoke, urging early detection, prevention, and expert evaluation for high-risk ...

From diagnosis methods to management of comorbid infections, new lung cancer protocols adaptable for various conditions ...

The EU-ME3 Ultrasound Processor provides clear visualization and assists in diagnostic, therapeutic and interventional ...

Interstitial lung abnormalities (ILAs) are parenchymal lung changes found on high-resolution CT. In routine use of high-resolution CT, non-specific findings are frequently reported, which has prompted ...

Detailed price information for Bioaffinity Technologies Inc (BIAF-Q) from The Globe and Mail including charting and trades.

Medical experts report rising lung cancer diagnoses in non-smokers as smoking rates decline, raising questions about expanding screening guidelines beyond traditional high-risk groups.

Background: This study investigates the use of CT radiomics combined with convolutional neural networks (CNN) to predict the malignancy of lung ground glass nodules (GGN), which are challenging to ...

The new lung cancer screening program needs to be independently evaluated to keep it on track, and to minimise the harms.